Skip to main content
. 2013 Sep 30;14(10):19731–19762. doi: 10.3390/ijms141019731

Table 1.

Oncogenes in PDAC: genetic aberration percentual and type.

Molecular target Genetic aberration (%) Type aberration
EGFR 43%–69% overexpression
VEGF 93% overexpression
KRAS 90% point mutation
BRAF 30% point mutation
AKT2 15% amplification
MYB 10% amplification
IGF-1R 64% amplification
MMPs 85% amplification
Hedgeogh 70% amplification
m-TOR 65% overexpression
MEK 72% point mutation
COX-2 67%–90% point mutation